Why it’s better and when it’s coming to market.

How this new standard paves the way for future artificial pancreas development.

Submitted to the FDA and could be approved this year.

One of the highlights of this year’s ADA Exhibit Hall was NeuroMetrix’s Quell chronic pain management device. Quell is the over the counter version (no prescription...

The company’s ambitious goal to reach 20 million patients by 2020.

Twitter summary: mySugr Academy helps people w/ #T2D tame their #diabetes monster in this 10-part video series – first two videos free! mySugr recently released the...

Bigfoot Biomedical has purchased all of Asante’s insulin pump resources, just two weeks after Asante closed down its business. The startup’s current plan is to pair the...

Twitter Summary: At #CES2015, @DrPhil discusses the DoctorOnDemand app - gives access to physicians + psychologists in under 2 min. for $50 or less! At the Consumer...

Complete with a savings card, a patient coaching program, and more!

Complete with color touchscreen, Bluetooth, and Dexcom integration. Potentially coming in 2016.

Twitter summary: Novo Nordisk gives patients individualized care strategy w/ #Diabetes Health Coach In early November, Novo Nordisk re-launched its Cornerstones4Care...

Solving the problem - "When did I last take my insulin?" - through a simple, easy to use design.

Dexcom announced FDA approval of the new G4 Platinum Share CGM receiver. The new device will be identical to the previous receiver, except that it will include built-in...

Plus, the latest on the new Bluetooth Share Receiver and the Tandem t:slim G4.

Integrated care, artificial pancreas, and personalized treatments – the goals of this innovative partnership.

DiabetesMine’s Innovation Summit shares updates on device connectivity, stigma research, the Bionic Pancreas, and more!

Find out if you qualify for this cutting-edge trial.

The latest on Medtronic’s drive to close the loop!

"If you gave me a fully self-driving car today, I wouldn’t use it. It would take me many months before I could build the confidence. We can’t just give patients the...

Josh Airth, a 17-year old with type 1 diabetes, recently participated in a clinical trial of the Medtronic 670G "hybrid-closed loop"system (insulin pump + Enlite 3 CGM...